Triamterene and Hydrochlorothiazide

Product NDC: 0591-0424
11-digit product format: 005910424
Labeler code: 0591
Product ID: 0591-0424_31975473-b876-48d4-81f4-b322137d8900
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Triamterene and Hydrochlorothiazide
Dosage form: TABLET
Route: ORAL
Labeler: Actavis Pharma, Inc.
Application: ANDA073449
Marketing category: ANDA
Marketing start: 1993-09-23
Substance: HYDROCHLOROTHIAZIDE; TRIAMTERENE
Active strength: 25; 37.5 mg/1; mg/1
Pharmacologic classes: Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
unfinished product	product	0591-0424		UNFINISHED	Active or certified unfinished drug listing	2026-08-17
unfinished package	package	0591-0424	0591-0424-00	UNFINISHED	Active or certified unfinished drug listing	2026-08-17
unfinished package	package	0591-0424	0591-0424-77	UNFINISHED	Active or certified unfinished drug listing	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 53 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 21:27 UTC · source 2025-12-05	unfinished product	product		`a6255e0c9aa5…`	`a0211a219f2e…`
2025-12-14 21:27 UTC · source 2025-12-05	unfinished package	package	0591-0424-00	`a6255e0c9aa5…`	`a0211a219f2e…`
2025-12-14 21:27 UTC · source 2025-12-05	unfinished package	package	0591-0424-77	`a6255e0c9aa5…`	`a0211a219f2e…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished product	product		`1d862106b807…`	`00c93037cd84…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished package	package	0591-0424-00	`1d862106b807…`	`00c93037cd84…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished package	package	0591-0424-77	`1d862106b807…`	`00c93037cd84…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished product	product		`390b4c401c3f…`	`2c692c2daee3…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished package	package	0591-0424-00	`390b4c401c3f…`	`2c692c2daee3…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished package	package	0591-0424-77	`390b4c401c3f…`	`2c692c2daee3…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished product	product		`e30019b0c005…`	`a3f0b14938b7…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished package	package	0591-0424-00	`e30019b0c005…`	`a3f0b14938b7…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished package	package	0591-0424-77	`e30019b0c005…`	`a3f0b14938b7…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished product	product		`bbbc9f937eca…`	`946b9c97cf81…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished package	package	0591-0424-00	`bbbc9f937eca…`	`946b9c97cf81…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished package	package	0591-0424-77	`bbbc9f937eca…`	`946b9c97cf81…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished product	product		`f268b84574a6…`	`26285f5ac5df…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished package	package	0591-0424-00	`f268b84574a6…`	`26285f5ac5df…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished package	package	0591-0424-77	`f268b84574a6…`	`26285f5ac5df…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished product	product		`f764e8902f78…`	`92046438deef…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished package	package	0591-0424-00	`f764e8902f78…`	`92046438deef…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished package	package	0591-0424-77	`f764e8902f78…`	`92046438deef…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished product	product		`68b1e3bced9e…`	`98a755eb8bc6…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished package	package	0591-0424-00	`68b1e3bced9e…`	`98a755eb8bc6…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished package	package	0591-0424-77	`68b1e3bced9e…`	`98a755eb8bc6…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished product	product		`05c55d027831…`	`ca05dca9dc4c…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished package	package	0591-0424-77	`05c55d027831…`	`ca05dca9dc4c…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished package	package	0591-0424-00	`05c55d027831…`	`ca05dca9dc4c…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished product	product		`48b4f40e6753…`	`c7c7a00d2afa…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished package	package	0591-0424-77	`48b4f40e6753…`	`c7c7a00d2afa…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished package	package	0591-0424-00	`48b4f40e6753…`	`c7c7a00d2afa…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished product	product		`27f29a85d7e4…`	`1372111e901f…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished package	package	0591-0424-77	`27f29a85d7e4…`	`1372111e901f…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished package	package	0591-0424-00	`27f29a85d7e4…`	`1372111e901f…`
2024-07-10 04:00 UTC · source 2024-07-09	unfinished product	product		`8d62ce987f31…`	`9fe9ef23e30d…`
2024-07-10 04:00 UTC · source 2024-07-09	unfinished package	package	0591-0424-00	`8d62ce987f31…`	`9fe9ef23e30d…`
2024-05-28 21:11 UTC · source 2024-05-28	unfinished product	product		`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-28 21:11 UTC · source 2024-05-28	unfinished package	package	0591-0424-00	`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-15 03:51 UTC · source 2024-05-14	unfinished product	product		`50b4072663b7…`	`eae3003ed65e…`
2024-05-15 03:51 UTC · source 2024-05-14	unfinished package	package	0591-0424-00	`50b4072663b7…`	`eae3003ed65e…`
2022-04-09 23:13 UTC · source 2022-04-08	unfinished product	product		`906f6e251498…`	`bf70b80e44f0…`
2022-04-09 23:13 UTC · source 2022-04-08	unfinished package	package	0591-0424-00	`906f6e251498…`	`bf70b80e44f0…`
2021-12-27 23:28 UTC · source 2021-12-27	unfinished product	product		`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-12-27 23:28 UTC · source 2021-12-27	unfinished package	package	0591-0424-00	`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-02-18 23:40 UTC · source 2021-02-18	unfinished product	product		`8fc7167e32ce…`	`e96bbc724034…`
2021-02-18 23:40 UTC · source 2021-02-18	unfinished package	package	0591-0424-00	`8fc7167e32ce…`	`e96bbc724034…`
2020-12-18 03:04 UTC · source 2020-12-17	unfinished product	product		`4184dd79f89f…`	`545327b3e20f…`
2020-12-18 03:04 UTC · source 2020-12-17	unfinished package	package	0591-0424-00	`4184dd79f89f…`	`545327b3e20f…`
2020-06-10 20:45 UTC · source 2020-06-10	unfinished product	product		`4bd3596a7b87…`	`5c64c6f6865f…`
2020-06-10 20:45 UTC · source 2020-06-10	unfinished package	package	0591-0424-00	`4bd3596a7b87…`	`5c64c6f6865f…`
2019-12-08 06:16 UTC · source 2019-12-05	unfinished product	product		`263afe128892…`	`91768de4ddbe…`
2019-12-08 06:16 UTC · source 2019-12-05	unfinished package	package	0591-0424-00	`263afe128892…`	`91768de4ddbe…`
2019-06-01 22:24 UTC · source 2019-05-30	unfinished product	product		`5b2001dcd8f5…`	`54b53d4dc9e4…`
2019-06-01 22:24 UTC · source 2019-05-30	unfinished package	package	0591-0424-00	`5b2001dcd8f5…`	`54b53d4dc9e4…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25MG;37.5MG	TABLET / ORAL	AB		1993-09-23

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A073449-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A073449-001	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	25MG;37.5MG	TABLET / ORAL	AB	1993-09-23	`e64feba35796…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A073449-001	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A073449-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A073449-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A073449-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A073449-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A073449-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A073449-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A073449-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A073449-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A073449-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A073449-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A073449-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A073449-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A073449-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A073449-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A073449-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A073449-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A073449-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A073449-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A073449-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A073449-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A073449-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A073449-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A073449-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A073449-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A073449-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A073449-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A073449-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A073449-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A073449-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A073449-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A073449-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A073449-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A073449-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A073449-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A073449-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A073449-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A073449-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A073449-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A073449-001	AB	1	`e64feba35796…`

Additional Listing Data#

Finished product: Yes
Brand name base: Triamterene and Hydrochlorothiazide
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
TRIAMTERENE	25 mg/1
HYDROCHLOROTHIAZIDE	37.5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
0J48LPH2TH	Internal UNII lookup
WS821Z52LQ	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
310812	Internal RxNorm lookup
310818	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
abf2fe45-8b69-4d3c-981e-289c0aa3e98b	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c19ec24d-2c40-4b8d-7c20-500ffa3660a1	Product name	3	20260303
1199f4b7-b537-466c-9a1c-cb09131e9f8b	Product name	1	20251117
e1a63b6e-1877-c2c1-01a3-03ea2817aa6f	Product name	3	20251027
b15e9aa6-d523-ca97-480e-570e0543a342	Product name	4	20251024
96816964-c075-ffa7-b7b8-d8570411a3b9	Product name	7	20250305
162cbc9d-ecc3-72ba-af9f-c76e2756ef54	Product name	3	20221207
9b303cd4-3186-2454-5706-3137e8b2dfd2	Product name	4	20221110
47fc2fe9-7afb-4be9-989d-787aaa6ad0ea	Product name	1	20200505
b2ea36e8-564d-01b9-8552-a327d058eb0f	Product name	2	20200203
a8e65197-7914-7acf-c7ec-914d53819b34	Product name	3	20190624
8b67f333-47d1-8464-7ce4-406d3dbb295f	Product name	7	20190618
89a57420-ab44-5323-14f9-595159145f9b	Product name	2	20190612
c27b049d-3258-48cf-ebe5-08c236ae78e2	Product name	3	20190610
00fc2cf9-672f-3e0b-6afa-43cbc864d058	Product name	4	20180613
15b375b1-89c7-9594-80df-5a8c8864aee0	Product name	3	20180108
a7349398-661d-d9fc-46df-7e128bbd61d9	Product name	5	20171113
1bdb87cf-9b1f-6a51-5eb7-d182aaffaa3d	Product name	2	20170719
e0eeb018-194e-4b70-a57d-bac47a97b8ea	Product name	1	20160825
55bffd21-17e1-ff02-2e8f-1f9a532b9502	Product name	2	20150320
ea069444-e874-4c28-833f-d2f52734ef4d	Product name	1	20150206
041df61b-f8b6-48a6-7b67-411e1412678b	Product name	1	20140508
0ad8bdca-888e-00da-648b-6a4de854a167	Product name	1	20140508
433a3439-b8f3-d13a-d2c8-9b221d628d60	Product name	1	20140508
59212689-39e5-a976-6d21-882d76d8079a	Product name	1	20140508
7613b1a5-acb6-4e5e-6048-c44deeeb1212	Product name	1	20140508
78637fb0-95c8-441f-e4b4-db1274b6f956	Product name	1	20140508
df89bd47-2db4-d593-ab37-d11953fd5536	Product name	1	20140508
f151007d-265d-9fbe-857d-1d44f1cb76ba	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0591-0424-01	Triamterene and Hydrochlorothiazide	100 in 1 BOTTLE, PLASTIC	TABLET	100		17
0591-0424-05	Triamterene and Hydrochlorothiazide	500 in 1 BOTTLE, PLASTIC	TABLET	500		17

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0591-0424-01	EA - Each	0591-0424	479b914e-4724-4955-9dca-043a305d74ac	1	2012-07-24
0591-0424-05	EA - Each	0591-0424	30863731-fc36-4456-a9db-6e200a57f9fd	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [WATSON LABORATORIES, INC.]	9
TRIAMTERENE	ACTIVE INGREDIENT	WS821Z52LQ	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [WATSON LABORATORIES, INC.]	9
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [WATSON LABORATORIES, INC.]	9
TRIAMTERENE	ACTIVE MOIETY	WS821Z52LQ	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [WATSON LABORATORIES, INC.]	9
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [WATSON LABORATORIES, INC.]	9
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [WATSON LABORATORIES, INC.]	9
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [WATSON LABORATORIES, INC.]	9
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [WATSON LABORATORIES, INC.]	9
POLACRILIN POTASSIUM	INACTIVE INGREDIENT	0BZ5A00FQU	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [WATSON LABORATORIES, INC.]	9
POLYETHYLENE GLYCOL 8000	INACTIVE INGREDIENT	Q662QK8M3B	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [WATSON LABORATORIES, INC.]	9
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [WATSON LABORATORIES, INC.]	9
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PD-RX PHARMACEUTICALS, INC.]	3
TRIAMTERENE	ACTIVE INGREDIENT	WS821Z52LQ	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PD-RX PHARMACEUTICALS, INC.]	3
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PD-RX PHARMACEUTICALS, INC.]	3
TRIAMTERENE	ACTIVE MOIETY	WS821Z52LQ	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PD-RX PHARMACEUTICALS, INC.]	3
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PD-RX PHARMACEUTICALS, INC.]	3
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PD-RX PHARMACEUTICALS, INC.]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PD-RX PHARMACEUTICALS, INC.]	3
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PD-RX PHARMACEUTICALS, INC.]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PD-RX PHARMACEUTICALS, INC.]	3
POLACRILIN POTASSIUM	INACTIVE INGREDIENT	0BZ5A00FQU	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PD-RX PHARMACEUTICALS, INC.]	3
POLYETHYLENE GLYCOL 8000	INACTIVE INGREDIENT	Q662QK8M3B	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PD-RX PHARMACEUTICALS, INC.]	3
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PD-RX PHARMACEUTICALS, INC.]	3
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
TRIAMTERENE	ACTIVE INGREDIENT	WS821Z52LQ	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
TRIAMTERENE	ACTIVE MOIETY	WS821Z52LQ	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
POLACRILIN POTASSIUM	INACTIVE INGREDIENT	0BZ5A00FQU	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
POLYETHYLENE GLYCOL 8000	INACTIVE INGREDIENT	Q662QK8M3B	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [STAT RX USA LLC]	1
TRIAMTERENE	ACTIVE INGREDIENT	WS821Z52LQ	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
TRIAMTERENE	ACTIVE INGREDIENT	WS821Z52LQ	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [STAT RX USA LLC]	1
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [STAT RX USA LLC]	1
TRIAMTERENE	ACTIVE MOIETY	WS821Z52LQ	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
TRIAMTERENE	ACTIVE MOIETY	WS821Z52LQ	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [STAT RX USA LLC]	1
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [STAT RX USA LLC]	1
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [STAT RX USA LLC]	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [STAT RX USA LLC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [STAT RX USA LLC]	1
POLACRILIN POTASSIUM	INACTIVE INGREDIENT	0BZ5A00FQU	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
POLACRILIN POTASSIUM	INACTIVE INGREDIENT	0BZ5A00FQU	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [STAT RX USA LLC]	1
POLYETHYLENE GLYCOL 8000	INACTIVE INGREDIENT	Q662QK8M3B	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
POLYETHYLENE GLYCOL 8000	INACTIVE INGREDIENT	Q662QK8M3B	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [STAT RX USA LLC]	1
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [STAT RX USA LLC]	1
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0591-0424	TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [ACTAVIS PHARMA, INC.]	17	Current NDC, Legacy NDC, 2 package rows	20241212_abf2fe45-8b69-4d3c-981e-289c0aa3e98b.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 9 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Triamterene and Hydrochlorothiazide	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	REMEDYREPACK INC.	43425ec7-a2c0-41d8-b759-b7b5918949ce	2026-06-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 073449 application number: ANDA073449
Triamterene and Hydrochlorothiazide	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	NuCare Pharmaceuticals,Inc.	bdd4348d-928d-ef0b-e053-2a95a90aadb4	2026-02-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 073449 application number: ANDA073449
Triamterene and Hydrochlorothiazide	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	Preferred Pharmaceuticals, Inc.	6c4cd90b-44c0-4da5-8f26-f0fa465acce4	2026-01-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 073449 application number: ANDA073449
Triamterene and Hydrochlorothiazide	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	PD-Rx Pharmaceuticals, Inc.	e505484d-b600-4d13-a4b9-278dc4a2e73a	2025-10-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 073449 application number: ANDA073449
Triamterene and Hydrochlorothiazide	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	A-S Medication Solutions	f4f026f9-5f21-435e-8878-01dc9bbe2d66	2025-07-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 073449 application number: ANDA073449
Triamterene and Hydrochlorothiazide	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	Bryant Ranch Prepack	5f5c3ada-db41-4104-9bed-9a56439a7ea2	2024-10-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 073449 application number: ANDA073449
Triamterene and Hydrochlorothiazide	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	NuCare Pharmaceuticals,Inc.	7c214ebf-e0ed-6538-e053-2991aa0a8079	2024-07-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 073449 application number: ANDA073449
Triamterene and Hydrochlorothiazide	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	Actavis Pharma, Inc.	abf2fe45-8b69-4d3c-981e-289c0aa3e98b	2024-05-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 073449 application number: ANDA073449 ndc (product): 0591-0424
Triamterene and Hydrochlorothiazide	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	BluePoint Laboratories	b8a55c23-b509-4790-88fa-9dc9bacd4bbe	2024-03-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 073449 application number: ANDA073449

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
0J48LPH2TH	HYDROCHLOROTHIAZIDE	58-93-5	HYDROCHLOROTHIAZIDE
WS821Z52LQ	TRIAMTERENE	396-01-0	TRIAMTERENE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310812	triamterene 37.5 MG / hydroCHLOROthiazide 25 MG Oral Tablet	PSN	e505484d-b600-4d13-a4b9-278dc4a2e73a	21
310812	hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet	SCD	e505484d-b600-4d13-a4b9-278dc4a2e73a	21
310812	HCTZ 25 MG / triamterene 37.5 MG Oral Tablet	SY	e505484d-b600-4d13-a4b9-278dc4a2e73a	21
310812	triamterene 37.5 MG / hydroCHLOROthiazide 25 MG Oral Tablet	PSN	abf2fe45-8b69-4d3c-981e-289c0aa3e98b	17
310818	triamterene 75 MG / hydroCHLOROthiazide 50 MG Oral Tablet	PSN	abf2fe45-8b69-4d3c-981e-289c0aa3e98b	17
310812	hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet	SCD	abf2fe45-8b69-4d3c-981e-289c0aa3e98b	17
310818	hydrochlorothiazide 50 MG / triamterene 75 MG Oral Tablet	SCD	abf2fe45-8b69-4d3c-981e-289c0aa3e98b	17
310812	HCTZ 25 MG / triamterene 37.5 MG Oral Tablet	SY	abf2fe45-8b69-4d3c-981e-289c0aa3e98b	17
310818	HCTZ 50 MG / triamterene 75 MG Oral Tablet	SY	abf2fe45-8b69-4d3c-981e-289c0aa3e98b	17
310812	triamterene 37.5 MG / hydroCHLOROthiazide 25 MG Oral Tablet	PSN	f4f026f9-5f21-435e-8878-01dc9bbe2d66	13
310812	hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet	SCD	f4f026f9-5f21-435e-8878-01dc9bbe2d66	13
310812	HCTZ 25 MG / triamterene 37.5 MG Oral Tablet	SY	f4f026f9-5f21-435e-8878-01dc9bbe2d66	13
310812	triamterene 37.5 MG / hydroCHLOROthiazide 25 MG Oral Tablet	PSN	6c4cd90b-44c0-4da5-8f26-f0fa465acce4	7
310812	hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet	SCD	6c4cd90b-44c0-4da5-8f26-f0fa465acce4	7
310812	HCTZ 25 MG / triamterene 37.5 MG Oral Tablet	SY	6c4cd90b-44c0-4da5-8f26-f0fa465acce4	7
310812	triamterene 37.5 MG / hydroCHLOROthiazide 25 MG Oral Tablet	PSN	5f5c3ada-db41-4104-9bed-9a56439a7ea2	6
310812	hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet	SCD	5f5c3ada-db41-4104-9bed-9a56439a7ea2	6
310812	HCTZ 25 MG / triamterene 37.5 MG Oral Tablet	SY	5f5c3ada-db41-4104-9bed-9a56439a7ea2	6
310812	triamterene 37.5 MG / hydroCHLOROthiazide 25 MG Oral Tablet	PSN	f7078eb5-f5fa-4067-94c5-93c1650db52c	5
310812	hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet	SCD	f7078eb5-f5fa-4067-94c5-93c1650db52c	5
310812	HCTZ 25 MG / triamterene 37.5 MG Oral Tablet	SY	f7078eb5-f5fa-4067-94c5-93c1650db52c	5
310812	triamterene 37.5 MG / hydroCHLOROthiazide 25 MG Oral Tablet	PSN	4e7af293-8d6e-41b0-e054-00144ff8d46c	4
310812	triamterene 37.5 MG / hydroCHLOROthiazide 25 MG Oral Tablet	PSN	7c214ebf-e0ed-6538-e053-2991aa0a8079	4
310812	hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet	SCD	7c214ebf-e0ed-6538-e053-2991aa0a8079	4
310812	hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet	SCD	4e7af293-8d6e-41b0-e054-00144ff8d46c	4
310812	HCTZ 25 MG / triamterene 37.5 MG Oral Tablet	SY	7c214ebf-e0ed-6538-e053-2991aa0a8079	4
310812	HCTZ 25 MG / triamterene 37.5 MG Oral Tablet	SY	4e7af293-8d6e-41b0-e054-00144ff8d46c	4
310812	triamterene 37.5 MG / hydroCHLOROthiazide 25 MG Oral Tablet	PSN	75d80f11-5c51-df34-e053-2991aa0a67c2	3
310812	hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet	SCD	75d80f11-5c51-df34-e053-2991aa0a67c2	3
310812	HCTZ 25 MG / triamterene 37.5 MG Oral Tablet	SY	75d80f11-5c51-df34-e053-2991aa0a67c2	3
310812	triamterene 37.5 MG / hydroCHLOROthiazide 25 MG Oral Tablet	PSN	bdd4348d-928d-ef0b-e053-2a95a90aadb4	2
310812	hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet	SCD	bdd4348d-928d-ef0b-e053-2a95a90aadb4	2
310812	HCTZ 25 MG / triamterene 37.5 MG Oral Tablet	SY	bdd4348d-928d-ef0b-e053-2a95a90aadb4	2
310812	triamterene 37.5 MG / hydroCHLOROthiazide 25 MG Oral Tablet	PSN	58912e7f-e2a2-44a5-ad38-31f95bbb9509	1
310812	triamterene 37.5 MG / hydroCHLOROthiazide 25 MG Oral Tablet	PSN	11a76fc1-5a1e-0509-e054-00144ff88e88	1
310818	triamterene 75 MG / hydroCHLOROthiazide 50 MG Oral Tablet	PSN	11a76fc1-5a1e-0509-e054-00144ff88e88	1
310812	hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet	SCD	58912e7f-e2a2-44a5-ad38-31f95bbb9509	1
310812	hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet	SCD	11a76fc1-5a1e-0509-e054-00144ff88e88	1
310818	hydrochlorothiazide 50 MG / triamterene 75 MG Oral Tablet	SCD	11a76fc1-5a1e-0509-e054-00144ff88e88	1
310812	HCTZ 25 MG / triamterene 37.5 MG Oral Tablet	SY	58912e7f-e2a2-44a5-ad38-31f95bbb9509	1
310812	HCTZ 25 MG / triamterene 37.5 MG Oral Tablet	SY	11a76fc1-5a1e-0509-e054-00144ff88e88	1
310818	HCTZ 50 MG / triamterene 75 MG Oral Tablet	SY	11a76fc1-5a1e-0509-e054-00144ff88e88	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0591-0424-00	00591042400	49800 TABLET in 1 BAG (0591-0424-00)	49800 tablet	23-SEP-93	31-MAR-28			Historical
0591-0424-01	00591042401	100 TABLET in 1 BOTTLE, PLASTIC (0591-0424-01)	100 tablet	1993-09-23	0000-00-00	No	No	Current
0591-0424-05	00591042405	500 TABLET in 1 BOTTLE, PLASTIC (0591-0424-05)	500 tablet	1993-09-23	0000-00-00	No	No	Current
0591-0424-77	00591042477	59700 TABLET in 1 CONTAINER (0591-0424-77)	59700 tablet	31-JUL-24	30-JUN-28			Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Triamterene and Hydrochlorothiazide Tablets, USP Rx only	REMEDYREPACK INC.	2026-06-01	HUMAN PRESCRIPTION DRUG LABEL	17
Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2020 Rx only	NuCare Pharmaceuticals,Inc.	2026-02-20	HUMAN PRESCRIPTION DRUG LABEL	2
Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2020 Rx only	Preferred Pharmaceuticals, Inc.	2026-01-13	HUMAN PRESCRIPTION DRUG LABEL	7
Triamterene and Hydrochlorothiazide Tablets, USP Rx only	PD-Rx Pharmaceuticals, Inc.	2025-10-20	HUMAN PRESCRIPTION DRUG LABEL	21
Triamterene and Hydrochlorothiazide Tablets, USP Rx only	A-S Medication Solutions	2025-07-10	HUMAN PRESCRIPTION DRUG LABEL	13
Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2014 Rx only	Lake Erie Medical DBA Quaity Care Products LLC \| Lake Erie Medical DBA Quality Care Products LLC	2025-01-21	HUMAN PRESCRIPTION DRUG LABEL	7
Triamterene and Hydrochlorothiazide Tablets, USP Rx only	Bryant Ranch Prepack	2024-10-07	HUMAN PRESCRIPTION DRUG LABEL	6
Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2014 Rx only	NuCare Pharmaceuticals,Inc.	2024-07-16	HUMAN PRESCRIPTION DRUG LABEL	4
Triamterene and Hydrochlorothiazide Tablets, USP Rx only	Actavis Pharma, Inc.	2024-05-01	HUMAN PRESCRIPTION DRUG LABEL	17
Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2020 Rx only	RPK Pharmaceuticals, Inc.	2023-06-07	HUMAN PRESCRIPTION DRUG LABEL	5
Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2020 Rx only	Northwind Pharmaceuticals, LLC	2023-01-20	HUMAN PRESCRIPTION DRUG LABEL	1
Triamterene and Hydrochlorothiazide - RedPharm Drug, Inc.	RedPharm Drug, Inc.	2022-01-20	HUMAN PRESCRIPTION DRUG LABEL	4
Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2014 Rx only	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	2021-01-26	HUMAN PRESCRIPTION DRUG LABEL	3
Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2014 Rx only	NuCare Pharmaceuticals, Inc.	2020-01-21	HUMAN PRESCRIPTION DRUG LABEL	2
Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2014 Rx only	Preferred Pharmaceuticals, Inc.	2017-11-16	HUMAN PRESCRIPTION DRUG LABEL	4
Triamterene and Hydrochlorothiazide Tablets USP Revised: April 2012 Rx only	Blenheim Pharmacal, Inc.	2015-03-19	HUMAN PRESCRIPTION DRUG LABEL	1
Triamterene and Hydrochlorothiazide Tablets USP Revised: April 2012 Rx only	STAT Rx USA LLC \| PSS World Medical Inc.	2012-09-25	HUMAN PRESCRIPTION DRUG LABEL	1